DOCSLIB.ORG

Isolation and Purification of Colicin Ecl 12, a Bacteriocin That Inhibits Strains of Escherichia Coli 0157:H7t

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Isolation and Purification of Colicin Ecl 12, a Bacteriocin That Inhibits Strains of Escherichia Coli 0157:H7t 1520 Journal oj'Food Protection, Vol. 60, No. 12, 1997, Pages 1520-1528 Copyright©, International Association of Milk, Food and Environmental Sanitarians Isolation and Purification of Colicin ECl 12, a Bacteriocin That Inhibits Strains of Escherichia coli 0157:H7t WANDA J. LYONH and DENNIS G. OLSON2 Downloaded from http://meridian.allenpress.com/jfp/article-pdf/60/12/1520/2301394/0362-028x-60_12_1520.pdf by guest on 01 October 2021 IDepartment of Food Science, Louisiana State University Agricultural Center, Louisiana State University, BalOn Rouge, Louisiana 70803; and 2Department oj'Animal Science, 10wa State University, Ames, 10wa 50011, USA (MS# 96-299: Received 28 October 1996/Accepted 16 March 1997) ABSTRACT tion of raw milk (6, 8). Vegetables, water, and other meat products have also been linked as vehicles for transmission A swine fecal isolate, identified as Escherichia coli ECLl2, of E. coli 0157:H7 infections (17). was found to produce an antimicrobial substance designated as The work reported in this paper was initiated with the colicin ECLl2. Colicin ECLl2 was inhibitory against 20 strains of purpose of finding bacteriocin-producing strains that could E. coli 0157:H7 previously isolated from both human and bovine effectively inhibit E. coli 0157:H7. Since cattle are reser- feces. Identification of the producer strain was determined pheno- voirs for E. coli 0157:H7, bovine feces were examined for typically by biochemical and morphological tests. Colicin ECLl2 was sensitive to several proteolytic enzymes. Adsorption of colicin bacteria that might have developed a selective advantage in ECLl2 to sensitive cells of E. coli 0157:H7 was bactericidal, animals that have not tested positive for shedding of E. coli resulting in a 2 log reduction in viable cell counts. CoLicinECLl2 0157:H7. In this study a bacteriocin produced by a species was purified from strain ECLl2 by cell extraction and ion- of E. coli was isolated, purified, and found to be a protein exchange chromatography. Sodium dodecyl sulfate-polyacryl- with antimicrobial activity against a narrow spectrum of amide gel electrophoresis of colicin ECLl2 resolved a single microorganisms, including strains of E. coli and Shigella protein with a molecular weight of approximately 65,000. sonnei. Key words: Colicin, inhibition, E. coli 0157:H7, food preservative MATERIALS AND METHODS Colicins are antimicrobial proteins synthesized by Esch- Cultures and media erichia coli and active against closely related coliform Escherichia coli ECL 12 was isolated from bovine sewage runoff as described below. The use of colicin ECL 12 in foods and bacteria. Colicin proteins range in molecular weight from the strain that produces it are protected by U.S. patent 5,549,895. 90,000 to 1,500 (12). Colicins are typically encoded on All microorganisms used in this study were grown in media and at plasmids with the exception of colicin Land microcin E966 temperatures indicated in Tables 1 and 2. Bacteriocin-producing (12, 18). A large number of colicins have been isolated and strain E. coli ECLl2 and sensitive E. coli 0157:H7 indicator strains characterized by many investigators, For additional perti- were propagated at 37°C in Trypticase soy broth (TSB) (BBL, nent information the reader is directed to previously pub- Becton Dickinson, Cockeysville, MD) supplemented with 0.5% lished reviews (12, 18). yeast extract (TSYE) (Difco Laboratories, Detroit, MI). Frozen Enterohemorrhagic E. coli (EHEC) strains, which in- stocks were maintained at -80°C in the appropriate medium with clude E. coli 0157:H7, are increasingly becoming recog- 50% glycerol. nized as widespread foodbome pathogens. Enterohemor- rhagic E. coli 0157:H7 causes serious illness in humans in Isolation of bacteriocin-producing bacteria the form of bloody diarrhea and hemolytic uremic syndrome Twenty-five fecal samples were obtained from several Iowa (17). EHEC strains are commonly isolated from the feces of farms. The fecal samples (25 g) were weighed into stomacher bags, clinically normal and diarrheic cattle (22). Cattle have been and 250 ml of phosphate buffer (pH 7.0) was added, the bags implicated as a reservoir for E. coli 0157:H7 (8). Human sealed, the material macerated for 5 min in a stomacher. SampLes were removed and serially diluted in 0.2% peptone, spread-plated infections and zoonotic transmission of E. coli 0157:H7 are onto both TSYE agar and violet red bile agar (VRBA) (Difco thought to occur by ingestion of ground beef and consump- Laboratories), and incubated aerobically at 37°C for 18 h. Indi- vidual colonies were transferred from VRBA plates with sterile toothpicks onto duplicate plates of TSYE and reincubated for 18h. * Author for correspondence. Tel: 504-388-5197; Fax: 504-388-5300; One plate was used for replica plating onto fresh TSYE plates and E-mail: [email protected]. the other was retained as a master plate. After growth, each plate t Joumal paper no. J-96-21-0273 of the Louisiana Agricultural Experiment was overlaid with 5 ml of TSYE containing 0.7% agar that had Station, Baton Rouge, LA. Project: S-263. been previously inoculated with different sensitive strains (20 Ill; COLICIN ECL12 1521 TABLE 1. The inhibitory effect of purified colicin ECLl2 against lated, and all were further characterized and identified as either selected gram-negative bacterial strains using the critical dilution Shigella sonnei, E. coli, or Klebsiella pneumoniae using both the method API 20E analysis as described by the manufacturer (API Analytab Products, Plainview, NY) and phenotypic characteristics listed in Reaction Table 3. Forty-five of the 50 bacteriocin-producing isolates pro- Growth to colicin duced antimicrobial activity that was not effective against E. coli Straina conditions ECL12b 0157:H7. One of the remaining isolates was characterized and Aeromonas hydrophila TSYE,37°C identified as a strain of E. coli and was found to produce an Campylobacter jejuni Thioglycollate, 37°C antimicrobial agent effective against E. coli 0157:H7. This isolate, Escherichia coli JM109 TSYE,37°C ++++ designated E. coli ECLl2, was selected for further characterization, Escherichia coli V517 TSYE,37°C ++++ isolation, and purification of its colicin. Escherichia coli 0157:H7 2903 TSYE,37°C ++++ Escherichia coli 0157:H7 2922 TSYE,37°C ++ Critical dilution assay for colicin activity Escherichia coli 0157:H7 3076 TSYE,37°C +++ Antagonistic activities of colicin ECLl2 preparations were Escherichia coli 0157:H7 2881 TSYE,37°C ++++ confirmed by spotting 5 fll of serially diluted (twofold dilution) Downloaded from http://meridian.allenpress.com/jfp/article-pdf/60/12/1520/2301394/0362-028x-60_12_1520.pdf by guest on 01 October 2021 Escherichia coli 0157:H7 3061 TSYE,37°C +++ colicin solutions onto lawns of indicator organisms as described Escherichia coli 0157:H7 2976 TSYE,37°C +++ previously (13, 14). Approximately 20 fll of an 18-h indicator Escherichia coli 0157:H7 2962 TSYE,37°C +++ culture was added to 5 ml of TSYE soft agar overlays (106 Escherichia coli 0157:H7 2972 TSYE,37°C ++++ CPU/ml), and plates were incubated at 37°C for 18 h. Activity was Escherichia coli 0157:H7 2952 TSYE,37°C +++ defined as the reciprocal of the highest 1:2 dilution causing Escherichia coli 0157:H7 3066 TSYE,37°C +++ complete inhibition of the indicator lawn and was expressed as Escherichia coli 0157: TSYE,37°C ++++ arbitrary units (AU) per m!. All assays were performed in duplicate, H7 NADC 3081 and results presented are the means of duplicate trials. Escherichia coli 0157:H7 2924 TSYE,37°C +++ Escherichia coli 0157:H7 2934 TSYE,37°C ++++ Extraction and purification of colicin ECL12 from producer cells Escherichia coli 0157:H7 2888 TSYE,37°C +++ An 18-h culture of E. coli ECLl2 (3,000 mI) was grown to Escherichia coli 0157:H7 2842 TSYE,37°C ++ early stationary phase (109 cells/ml) in M9 broth (1) at 37°C. The Escherichia coli 0157:H7 FSIS TSYE,37°C +++ cell pellets were washed with 30 ml of 50 mM potassium phosphate 45956-59A buffer (pH 7.2) as described by Herschman and Helinski (9) with Escherichia coli 0157:H7 FSIS TSYE,37°C +++ the following modifications. After the cells had been washed and 45753-57B-31 pelleted by centrifugation at 12,000X g at 4°C, the colicin was Escherichia hermanii TSYE,37°C extracted from the cell pellet by resuspending the pellets in a total ATCC 33650 volume of 100 ml of 50 mM potassium phosphate buffer (pH 7.2) Escherichia fergusonii TSYE,37°C containing 1.0 M NaCl, 1 mM EDTA, 1 mM amidinophenylmeth- ATCC 35469 anesulfonyl fluoride (APMSF), and 1 mM pepstatin (all purchased Pseudomonas fluorescens BRr,32°C from Boehringer Mannheim, Indianapolis, IN). The suspension Pseudomonas aeruginosa BRr,32°C was homogenized at low speed with a Waring blender for 30 min at Salmonella derby TSYE,37°C Salmonella dublin TSYE,37°C Salmonella newington TSYE,37°C TABLE 2. The inhibitory effect of purified colicin ECLl2 against Salmonella typhimurium ATCC TSYE,37°C selected gram-positive bacterial strains using the critical dilution 14028 method Shigella dysenteriae TSYE,37°C Reaction Shigella sonnei TSYE,37°C ++++ Growth to colicin b Shigella sonnei ATCC 9290 TSYE,37°C +++ Selected strainsa conditions ECL12 Vibrio parahaemolyticus BRr,32°C Yersinia enterocolitica ATCC TSYE,37°C Bacillus cereus BRr,37°C 23715 Clostridium perfringens Meat, 37°C Enterococcus faecium TSYE,37°C a Strains with no designation are from the culture collection of the Listeria monocytogenes Scott A TSYE,32°C Department of Microbiology at Iowa State University. E. coli Lactobacillus bulgaricus MRS, 37°C . 0157:H7 strains were obtained from the National Animal Disease Lactococcus casei MRS, 37°C Center, Ames, IA. Pediococcus cerevisiae MRS, 37°C b The reaction was assayed by the critical dilution method de- Propionibacterium shermanii TSYE,32°C scribed in the text.
Load more

Recommended publications
  • Colicin E2 Is a DNA Endonuclease
    Proc. Nati. Acad. Sci. USA Vol. 73, No. 11, pp. 3989-S993'November 1976 Biochemistry Colicin E2 is a DNA endonuclease (colicin-E2-immunity protein/colicin E3/colicin-E3-immunity protein) KLAUS SCHALLER AND MASAYASU NOMURA University of Wisconsin, Institute for Enzyme Research, 1710 University Avenue, Madison, Wisc. 53706 Communicated by Henry Lardy, September 10, 1976 ABSTRACT Colicin E2 purified by conventional methods immunity protein (20). These authors demonstrated that the contains a tightly bound low-molecular-weight protein, as has immunity protein could be separated from the E3 protein by been found with purified colicin E3 [Jakes, N. & Zinder, N. D. preparative electrophoresis in sodium dodecyl sulfate/poly- (1974) Proc. Nat. Acad. Sci. USA 71, 3380-33841. Such E2 preparations do not cause DNA cleavage in vitro. After sepa- acrylamide gels and that E3 protein (called "ES*") free of ration from the low-molecular-weight protein, colicin E2 re- immunity protein was much more active than the "complexed" tained the original in vivo killing activity, and in addition ES preparation in ribosome inactivation in vitro (20). They also showed a high activity in vitro in cleaving various DNA mole- noted the presence of a small-molecular-weight protein in cules, such as a ColE1 hybrid plasmid and DNAs from Esche- highly purified E2 preparations (cited in ref. 20). From the richia coli, X phage, 4X174 phage, and simian virus 40. The low-molecular-weight protein ("E2-immunity protein") specif- analogy of the colicin E3-immunity protein complex, they ically prevented this in vitro DNA cleavage reaction, i.e., had inferred that this small-molecular-weight protein is probably an "immunity function." The results demonstrate that colicin the E2-immunity protein.
    [Show full text]
  • Broad and Efficient Control of Major Foodborne Pathogenic Strains Of
    Broad and efficient control of major foodborne PNAS PLUS pathogenic strains of Escherichia coli by mixtures of plant-produced colicins Steve Schulza,1, Anett Stephana,1, Simone Hahna,1, Luisa Bortesia,2, Franziska Jarczowskib, Ulrike Bettmannb, Anne-Katrin Paschkeb, Daniel Tuséc, Chad H. Stahld, Anatoli Giritcha,3, and Yuri Glebaa aNomad Bioscience GmbH, Biozentrum Halle, D-06120 Halle (Saale), Germany; bIcon Genetics GmbH, Biozentrum Halle, D-06120 Halle (Saale), Germany; cDT/Consulting Group, Sacramento, CA 95818; and dDepartment of Animal and Avian Sciences, University of Maryland, College Park, MD 20742 Edited by Charles J. Arntzen, Arizona State University, Tempe, AZ, and approved August 7, 2015 (received for review July 7, 2015) Enterohemorrhagic Escherichia coli (EHEC) is one of the leading involve heating or organic acids, which can adversely modify the causes of bacterial enteric infections worldwide, causing ∼100,000 taste and quality of the products. Currently approved bacteriophage illnesses, 3,000 hospitalizations, and 90 deaths annually in the United mixtures enable narrow and specific control of O157:H7 but not of States alone. These illnesses have been linked to consumption of other pathogenic strains (4). Use of traditional antibiotics for the contaminated animal products and vegetables. Currently, other than treatment of food is not appropriate and should be considered thermal inactivation, there are no effective methods to eliminate unacceptable, particularly due to the increase of antibiotic re- pathogenic bacteria in food. Colicins are nonantibiotic antimicrobial sistance seen among E. coli strains found in food (5). Among proteins, produced by E. coli strains that kill or inhibit the growth of nonantibiotic antibacterials, several colicins have been shown to be other E.
    [Show full text]
  • Colicin E1 Fragments Potentiate Antibiotics by Plugging Tolc
    bioRxiv preprint doi: https://doi.org/10.1101/692251; this version posted July 4, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Colicin E1 Fragments Potentiate Antibiotics by 2 Plugging TolC 3 4 S. Jimmy Budiardjoa, Jacqueline J. Deayb, Anna L. Calkinsc, Virangika K. Wimalasenab, 5 Daniel Montezano b, Julie S. Biteenc and Joanna S.G. Sluskya,b,1 6 7 aCenter for Computational Biology, The University of Kansas, 2030 Becker Dr., 8 Lawrence, KS 66045-7534 bDepartment of Molecular Biosciences, The University of 9 Kansas, 1200 Sunnyside Ave. Lawrence KS 66045 cDepartment of Chemistry, 10 University of Michigan, Ann Arbor MI 48109-1055 11 12 13 14 15 1To whom correspondence may be addressed. E-mail: [email protected] 785-864-6519 16 1 bioRxiv preprint doi: https://doi.org/10.1101/692251; this version posted July 4, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 17 Abstract 18 The double membrane architecture of Gram-negative bacteria forms a barrier 19 that is effectively impermeable to extracellular threats. Accordingly, researchers have 20 shown increasing interest in developing antibiotics that target the accessible, surface- 21 exposed proteins embedded in the outer membrane. TolC forms the outer membrane 22 channel of an antibiotic efflux pump in Escherichia coli. Drawing from prior observations 23 that colicin E1, a toxin produced by and lethal to E.
    [Show full text]
  • Isolation of Catenated and Replicating DNA Molecules of Colicin Factor El from Minicells (E
    Proc. Nat. Acad. Sci. USA Vol. 68, No. 11, pp. 2839-2842, November 1971 Isolation of Catenated and Replicating DNA Molecules of Colicin Factor El from Minicells (E. coli/sucrose gradients/ethidium bromide/CsCl/electron microscopy) JOSEPH INSELBURG AND MOTOHIRO FUKE* Department of Microbiology, Dartmouth Medical School, Hanover, New Hampshire 03755; and Department of Biological Chemistry, Harvard Medical School, Boston, Massachusetts 02115 Communicated by Luigi Gorini, September 14, 1971 ABSTRACT Various catenated and replicating mole- at 37°C) of minicells previously incubated in spheroplast cules of colicin El isolated from minicells have been medium was introduced into the DNA extraction procedure identified in regions of neutral sucrose density gradients or cesium chloride-ethidium bromide density gradients. before the addition of Sarkosyl NL30 and subsequent phenol These colicin molecules have been found in those regions extraction (2, 11). Neutral sucrose density gradient sedimen- of the gradient where pulse-labeled DNA accumulates. tation analysis (2) and cesium chloride-ethidium bromide (2,7-diamino-10-ethyl-9-phenylphenanthridium bromide) den- Adler et al. (1) isolated a mutant of Escherichia coli, P678-54, sity-gradient analysis of DNA (2, 12) and electron that produced significant numbers of small, DNA-less progeny microscope techniques (7, 13, 14) were also described in ("minicells") under normal growth conditions. Subsequent detail. Buffer solutions used are Tris-saline (TS) 0.05 M work has shown that if plasmid or episomal DNAs are carried Tris-0.05 M NaCl (pH 8.0); Tris-EDTA-Saline (TES), by that mutant, they can segregate into (2-6) and replicate which is TS + 5 mM EDTA; and saline-sodium citrate in (2, 6, 7) the minicells.
    [Show full text]
  • Structural and Functional Alterations of a Colicin-Resistant Mutant of Ompf
    Proc. Nati. Acad. Sci. USA Vol. 91, pp. 10675-10679, October 1994 Biophysics Structural and functional alterations of a colicin-resistant mutant of OmpF porin from Escherichia coli (bacteroi sentlty/coe N/porin channel/x-ray analysis) DENIS JEANTEUR*, TILMAN SCHIRMERt, DIDIER FOUREL0, VALERIE SIMONETt, GABRIELE RUMMEL§, CHRISTINE WIDMER§, JURG P. ROSENBUSCH§, FRANC PATTUS*¶, AND JEAN-MARIE PAGtSfII *European Molecular Biology Laboratory, Postfach 10.2209, Meyerhofstrasse 1, D-69012 Heidelberg, Germany; Departments of tStructural Biology and *Microbiology, Biozentrum, University of Basel, CH4056, Basel, Switzerland; and *Unit6 Propre de Recherche 9027, Centre de Biochimie et de Biologie Moleculaire, Centre National de la Recherche Scientifique, 31 Chemin Joseph-Aiguier, B.P. 71, Marseille Cedex 20, France Communicated by Eugene P. Kennedy, July 7, 1994 ABSTRACT A strain of Escherichia coli, selected on the residues that protrude from the barrel wall near the threefold basis of Its resistance to colicin N, reveals distinct structural molecular axis, faces two acidic side chains located on L3. and functional alterations in unspecific OmpF porin. A single This establishes a strong electrostatic field parallel to the mutation [Gly-119 -- Asp (G119D)] was identified in the membrane plane (11). Of the four colicin N-resistant point internal loop L3 that contributes critically to the formation of mutations that have recently been isolated and characterized the constriction inside the lumen of the pore. X-ray structure in OmpF porin (7), three are located on the external loops, analysis to a resolution of 3.0 A reveals a locally altered presumably impairing binding ofthe toxin. The fourth is aGly peptide backbone, with the side chain of residue Asp-119 Asp substitution at position 119 (G119D), located in loop protruding into the channe, causing the area of the constric- L3, far from the external surface of the molecule.
    [Show full text]
  • Reconstitution of Membrane Proteins Into Model Membranes: Seeking Better Ways to Retain Protein Activities
    Int. J. Mol. Sci. 2013, 14, 1589-1607; doi:10.3390/ijms14011589 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Review Reconstitution of Membrane Proteins into Model Membranes: Seeking Better Ways to Retain Protein Activities Hsin-Hui Shen 1,2,*, Trevor Lithgow 1 and Lisandra L. Martin 2 1 Department of Biochemistry and Molecular Biology, Monash University, Melbourne 3800, Australia; E-Mail: [email protected] 2 School of Chemistry, Monash University, Clayton, VIC 3800, Australia; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +61-3-9545-8159. Received: 20 December 2012; in revised form: 9 January 2013 / Accepted: 10 January 2013 / Published: 14 January 2013 Abstract: The function of any given biological membrane is determined largely by the specific set of integral membrane proteins embedded in it, and the peripheral membrane proteins attached to the membrane surface. The activity of these proteins, in turn, can be modulated by the phospholipid composition of the membrane. The reconstitution of membrane proteins into a model membrane allows investigation of individual features and activities of a given cell membrane component. However, the activity of membrane proteins is often difficult to sustain following reconstitution, since the composition of the model phospholipid bilayer differs from that of the native cell membrane. This review will discuss the reconstitution of membrane protein activities in four different types of model membrane—monolayers, supported lipid bilayers, liposomes and nanodiscs, comparing their advantages in membrane protein reconstitution. Variation in the surrounding model environments for these four different types of membrane layer can affect the three-dimensional structure of reconstituted proteins and may possibly lead to loss of the proteins activity.
    [Show full text]
  • Colicin M for the Control of Ehec Colicin M Zur Kontrolle Von Ehec Colicine M Pour Le Contrôle De Ehec
    (19) *EP003097783B1* (11) EP 3 097 783 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: A01N 63/02 (2006.01) A01P 1/00 (2006.01) 13.11.2019 Bulletin 2019/46 (21) Application number: 15181133.8 (22) Date of filing: 14.08.2015 (54) COLICIN M FOR THE CONTROL OF EHEC COLICIN M ZUR KONTROLLE VON EHEC COLICINE M POUR LE CONTRÔLE DE EHEC (84) Designated Contracting States: • L.SARADA NANDIWADA ET AL: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB "Characterization of an E2-type colicin and its GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO application to treat alfalfa seeds to reduce PL PT RO RS SE SI SK SM TR Escherichia coli O157:H7", INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, vol. 93, no. (30) Priority: 26.05.2015 US 201562166379 P 3, 1 June 2004 (2004-06-01), pages 267-279, XP055226209, NL ISSN: 0168-1605, DOI: (43) Date of publication of application: 10.1016/j.ijfoodmicro.2003.11.009 30.11.2016 Bulletin 2016/48 • H. TOSHIMA ET AL: "Enhancement of Shiga Toxin Production in Enterohemorrhagic (73) Proprietor: Nomad Bioscience GmbH Escherichia coli Serotype O157:H7 by DNase 80333 München (DE) Colicins", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 73, no. 23, 1 December 2007 (72) Inventors: (2007-12-01), pages 7582-7588, XP055226172, US • GIRITCH, Anatoli ISSN: 0099-2240, DOI: 10.1128/AEM.01326-07 06108 Halle (DE) • DATABASE MEDLINE [Online] US NATIONAL • HAHN, Simone LIBRARY OF MEDICINE (NLM), BETHESDA, MD, 06217 Merseburg (DE) US; 2011, ETCHEVERRÍA A I ET AL: "Reduction • SCHULZ, Steve of Adherence of E.
    [Show full text]
  • Channel Formation by Antiapoptotic Protein Bcl-2
    Proc. Natl. Acad. Sci. USA Vol. 94, pp. 5113–5118, May 1997 Cell Biology Channel formation by antiapoptotic protein Bcl-2 SHARON L. SCHENDEL*†,ZHIHUA XIE*†,MYRTA OBLATT MONTAL†‡,SHIGEMI MATSUYAMA*, MAURICIO MONTAL‡§, AND JOHN C. REED*§ *Program on Apoptosis and Cell Death Research, The Burnham Institute, 10901 N. Torrey Pines Road, La Jolla, CA 92037; and ‡Department of Biology, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0366 Communicated by Carlo M. Croce, Thomas Jefferson University, Philadelphia, PA, March 4, 1997 (received for review January 15, 1997) ABSTRACT Bcl-2 is the prototypical member of a large Bcl-2 can regulate Ca21 fluxes and protein translocation across family of apoptosis-regulating proteins, consisting of blockers membranes (10–14), has prompted speculations that Bcl-2 family and promoters of cell death. The three-dimensional structure of proteins may be involved in some aspect of either ion or protein a Bcl-2 homologue, Bcl-XL, suggests striking similarity to the transport (1). Recently, the three-dimensional structure of Bcl- pore-forming domains of diphtheria toxin and the bacterial XL, an antiapoptotic homolog of Bcl-2, has been solved, revealing colicins, prompting exploration of whether Bcl-2 is capable of striking similarity to the pore-forming domains of diphtheria forming pores in lipid membranes. Using chloride efflux from toxin (DT) and the bacterial colicins (15). KCl-loaded unilamellar lipid vesicles as an assay, purified re- Bcl-XL, DT, and the colicins A and E1 all contain a pair of combinant Bcl-2 protein exhibited pore-forming activity with central hydrophobic a-helices, arranged in a hairpin structure properties similar to those of the bacterial toxins, diphtheria that is surrounded by 5–8 amphipathic a-helices.
    [Show full text]
  • Molecular Mechanisms of Colicin Evolution’
    Molecular Mechanisms of Colicin Evolution’ Margaret A. Riley Department of Biology, Yale University This review explores features of the origin and evolution of colicins in Escherichia coli. First, the evolutionary relationships of 16 colicin and colicin-related proteins are inferred from amino acid and DNA sequence comparisons. These comparisons are employed to detail the evolutionary mechanisms involved in the origin and diversification of colicin clusters. Such mechanisms include movement of colicin plasmids between strains of E. coli and subsequent plasmid cointegration, trans- position- and recombination-mediated transfer of colicin and related sequences, and rapid diversification of colicin and immunity proteins through the action of positive selection. The wealth of information contained in colicin sequence com- parisons makes this an ideal system with which to explore molecular mechanisms of evolutionary change. Introduction Colicins are toxic proteins produced by and active against Escherichia coli and related bacteria. Nineteen colicins have been described in E. coli, distinguished by the absence of cross-immunity between the producing strains (Fredericq 1957; Nomura 1967; Pugsley 1984, 1985). Although colicins differ in their precise mode of killing, they share ( 1) a similar genetic structure, including the usual presence of three colicin- related genes- a colicin, a lysis, and an immunity gene, termed a “colicin cluster”; (2) the lethality of colicin release from the cell; (3) the specific protection afforded by the immunity protein; and (4) carriage on plasmids (Hardy 1975; Pugsley 1984; Luria and Suit 1987). The biochemistry and molecular biology of colicins have been studied in great detail (reviewed in Konisky 1982; Luria and Suit 1987).
    [Show full text]
  • Analysis of the Genome and Outer Membrane Proteome
    pathogens Article How Bacteria Change after Exposure to Silver Nanoformulations: Analysis of the Genome and Outer Membrane Proteome Anna K˛edziora 1,* , Mateusz Speruda 1, Maciej Wernecki 1 , Bartłomiej Dudek 1, Katarzyna Kapczynska 2 , Eva Krzyzewska˙ 2 , Jacek Rybka 2 and Gabriela Bugla-Płosko ´nska 1,* 1 Department of Microbiology, Faculty of Biological Sciences, University of Wroclaw, 51-148 Wroclaw, Poland; [email protected] (M.S.); [email protected] (M.W.); [email protected] (B.D.) 2 Department of Immunology of Infectious Diseases, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland; [email protected] (K.K.); [email protected] (E.K.); [email protected] (J.R.) * Correspondence: [email protected] (A.K.); [email protected] (G.B.-P.); Tel.: +487-1375-6323 (A.K.) Abstract: Objective: the main purpose of this work was to compare the genetic and phenotypic changes of E. coli treated with silver nanoformulations (E. coli BW25113 wt, E. coli BW25113 AgR, E. coli J53, E. coli ATCC 11229 wt, E. coli ATCC 11229 var. S2 and E. coli ATCC 11229 var. S7). Silver, as the metal with promising antibacterial properties, is currently widely used in medicine and the biomedical industry, in both ionic and nanoparticles forms. Silver nanoformulations are usually Citation: K˛edziora,A.; Speruda, M.; considered as one type of antibacterial agent, but their physical and chemical properties determine Wernecki, M.; Dudek, B.; Kapczynska, the way of interactions with the bacterial cell, the mode of action, and the bacterial cell response K.; Krzyzewska,˙ E.; Rybka, J.; Bugla-Płosko´nska,G.
    [Show full text]
  • Inhibition of a Ribosome-Inactivating Ribonuclease: the Crystal Structure Of
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Research Article 949 Inhibition of a ribosome-inactivating ribonuclease: the crystal structure of the cytotoxic domain of colicin E3 in complex with its immunity protein Stephen Carr1, Daniel Walker2, Richard James2, Colin Kleanthous2 and Andrew M Hemmings1,2* Background: The cytotoxicity of most ribonuclease E colicins towards Addresses: Colicin Research Group, 1School of Escherichia coli arises from their ability to specifically cleave between bases Chemical Sciences, University of East Anglia, 2 1493 and 1494 of 16S ribosomal RNA. This activity is carried by Norwich NR4 7TJ, UK and School of Biological Sciences, University of East Anglia, Norwich the C-terminal domain of the colicin, an activity which if left unneutralised NR4 7TJ, UK. would lead to destruction of the producing cell. To combat this the host E. coli cell produces an inhibitor protein, the immunity protein, which forms *Corresponding author. a complex with the ribonuclease domain effectively suppressing its activity. E-mail: [email protected] Key words: crystal structure, immunity protein, Results: We have solved the crystal structure of the cytotoxic domain of the ribonuclease colicin, ribosome inactivation ribonuclease colicin E3 in complex with its immunity protein, Im3. The structure of the ribonuclease domain, the first of its class, reveals a highly twisted central Received: 18 April 2000 Revisions requested: 21 June 2000 β-sheet elaborated with a short N-terminal helix, the residues of which form a Revisions received: 11 July 2000 well-packed interface with the immunity protein.
    [Show full text]
  • The Role of the Bcl-2 Family in the Regulation of Outer Mitochondrial Membrane Permeability
    Cell Death and Differentiation (2000) 7, 1182 ± 1191 ã 2000 Macmillan Publishers Ltd All rights reserved 1350-9047/00 $15.00 www.nature.com/cdd Review The role of the Bcl-2 family in the regulation of outer mitochondrial membrane permeability 1 ,1 MH Harris and CB Thompson* Introduction 1 Abramson Family Cancer Research Institute, University of Pennsylvania, Mitochondria became the subject of intensive scientific Philadelphia, PA 19104, USA investigation in the mid-twentieth century when their role as * Corresponding author: CB Thompson, Abramson Family Cancer Research cellular energy producers was discovered. This culminated in Institute, 450 BRB II/III, 421 Curie Blvd., Philadelphia, PA 19104-6160, USA. the discovery and characterization of oxidative phosphoryla- E-mail: [email protected] tion as the mechanism by which most cellular ATP is Received 29.6.00; accepted 14.9.00 produced. Free exchange of substrate and ATP/ADP Edited by G Kroemer between mitochondria and the cytosol was proposed to provide the homeostatic mechanism by which glycolysis and oxidative phosphorylation are coupled to maintain the Abstract intracellular ATP/ADP ratio.1,2 In the last few years, there has been a resurgence of interest in mitochondria following Mitochondria are well known as sites of electron transport and the discovery that mitochondria play a crucial role in the generators of cellular ATP. Mitochondria also appear to be regulation of programmed cell death, or apoptosis.3±9 A sites of cell survival regulation. In the process of programmed number of molecules involved in the execution of apoptosis cell death, mediators of apoptosis can be released from normally reside in mitochondria, safely sequestered from their mitochondria through disruptions in the outer mitochondrial targets and co-factors.10 ± 16 Following an apoptotic stimulus, membrane; these mediators then participate in the activation these proteins can be released from mitochondria and initiate of caspases and of DNA degradation.
    [Show full text]